Literature DB >> 4176645

Heterogeneity of antibody response to Salmonella lipopolysaccharide measured by passive hemagglutination and hemolysis in mice.

J P Ransom, C Larson, J M Gorman, S Tulve.   

Abstract

The complement-requiring passive hemolysis test with Salmonella typhimurium lipopolysaccharide-coated sheep erythrocytes is more sensitive for antibodies directed against the lipopolysaccharide than is the passive hemagglutination test. The hemagglutinating and hemolyzing antibodies produced in Swiss mice by hyperimmunization, either with or without Freund's adjuvant, were distributed in both the light and heavy fractions isolated by sucrose density gradient fractionation and gel filtration. IgM fractions, whether tested by hemagglutination or hemolysis, were sensitive to 2-mercaptoethanol (0.15 m). On the other hand, IgG hemolytic antibodies were more sensitive to 2-mercaptoethanol than were IgG hemagglutinating antibodies. The resistance of IgG hemagglutinating activity amounted to about 72 to 95% of the total IgG recovered, whereas the resistant portion of the IgG hemolytic activity was approximately 40 to 53%. It is suggested that, although mercaptoethanol sensitivity is not a definitive test for IgM antibody, its use in connection with the hemagglutination test gives at least an approximation of the IgG antibody, whereas the hemolysis test gives a better approximation of maximal measurable antibody against Salmonella lipopolysaccharides.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4176645      PMCID: PMC252397          DOI: 10.1128/jb.96.4.909-915.1968

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  28 in total

Review 1.  Antibody heterogeneity and serological reactions.

Authors:  R M Pike
Journal:  Bacteriol Rev       Date:  1967-06

2.  Technique for volume production of mouse ascites fluid containing Bordetella pertussis antibody.

Authors:  R W March; D Cooney
Journal:  Appl Microbiol       Date:  1966-07

3.  Studies at the cellular level of the 19S immune response.

Authors:  H Wigzell; G Möller; B Andersson
Journal:  Acta Pathol Microbiol Scand       Date:  1966

4.  19S antibody production against soluble lipopolysaccharide antigens by individual lymphoid cells in vitro.

Authors:  G Möller
Journal:  Nature       Date:  1965-09-11       Impact factor: 49.962

5.  The immunoglobulins of mice. VI. Response to immunization.

Authors:  W F Barth; C L McLaughlin; J L Fahey
Journal:  J Immunol       Date:  1965-11       Impact factor: 5.422

6.  Immunochemical properties of human gamma-A isohemagglutinin. I. Comparisons with gamma-G and gamma-M-globulin antibodies.

Authors:  K Ishizaka; T Ishizaka; E H Lee; H Fudenberg
Journal:  J Immunol       Date:  1965-08       Impact factor: 5.422

7.  Precipitin activity of rabbit macroglobulin antibody.

Authors:  K Lindqvist; D C Bauer
Journal:  Immunochemistry       Date:  1966-09

8.  The immune response to heterologous red cells in mice.

Authors:  F M Dietrich
Journal:  Immunology       Date:  1966-04       Impact factor: 7.397

9.  Further studies on the secondary antibody-forming potential of juvenile, young adult, adult, and aged mice.

Authors:  T Makinodan; W J Peterson
Journal:  Dev Biol       Date:  1966-08       Impact factor: 3.582

10.  Agglutinating and precipitating capacity of rabbit anti-Salmonella typhosa gamma G and gamma M-antibodies during prolonged immunization.

Authors:  R M Pike; M L Schulze; C H Chandler
Journal:  J Bacteriol       Date:  1966-10       Impact factor: 3.490

View more
  2 in total

1.  Morphological examination of the glycocalyces of Staphylococcus aureus strains Wiley and Smith.

Authors:  G G Caputy; J W Costerton
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

2.  Antibody Response to Bacterial Antigens: Characteristics of Antibody Response to Somatic Antigens of Salmonella typhimurium.

Authors:  Y Fukazawa; T Shinoda; T Yomoda; T Tsuchiya
Journal:  Infect Immun       Date:  1970-03       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.